Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
SF3B1 mutation accelerates the development of CLL via activation of the mTOR pathway.
Journal: JCI insight
Published: July 02, 2024
SF3B1 mutation accelerates the development of CLL via activation of the mTOR pathway.
Journal: JCI insight
Published: July 02, 2024
Engineering Oncogenic Hotspot Mutations on SF3B1 via CRISPR-Directed PRECIS Mutagenesis.
Journal: Cancer research communications
Published: March 07, 2024
METTL3-Mediated m6A Modification Controls Splicing Factor Abundance and Contributes to Aggressive CLL.
Journal: Blood cancer discovery
Published: September 23, 2022
SF3B1 mutation and ATM deletion codrive leukemogenesis via centromeric R-loop dysregulation.
Journal: The Journal of clinical investigation
Published: July 12, 2022
Discovery of a pre-mRNA structural scaffold as a contributor to the mammalian splicing code.
Journal: Nucleic acids research
Published: February 06, 2021
Structural disruption of exonic stem-loops immediately upstream of the intron regulates mammalian splicing.
Journal: Nucleic acids research
Published: November 21, 2019
Showing 1-7 of 7
Last Updated: 09/26/2026